KPV has only three residues, which makes its name easy to remember and its specification easy to oversimplify. A buyer still needs to distinguish the reference structure from a supplier’s offered form and from the documents for a received lot. Short length is not evidence that every material carrying the name is equivalent.
Read the three letters in order
The PubChem record for Lys-Pro-Val identifies KPV and represents H-Lys-Pro-Val-OH. The letters mean lysine, proline and valine in that order. Preserve the order in the inquiry rather than listing amino acids as an unordered composition. A database reference helps define the intended molecule; it does not certify identity, purity or quantity in the proposed supply.
Write the terminal description as its own field
The compact KPV string does not visibly encode every feature of a complete structure. Put termini and stereochemical requirements alongside the sequence. If a supplier proposes a capped or modified form, ask for a separate structure and quotation line rather than accepting the change under the same nickname. The worksheet starts with the cited reference but deliberately leaves the actual supplied form for written confirmation.
| Field | Reference / request | Review status |
|---|---|---|
| Residues | Lys–Pro–Val / KPV | Supplier identity confirmation |
| Termini | H–KPV–OH in the cited reference | Actual offered structure |
| Chemical form | Counterion / salt statement | Separate from terminal modification |
| Mass | Per-container figure and basis | Declared or measured |
| Scope | Single material or blend component | Matching sample evidence |
Keep chemical form separate from covalent changes
A counterion description and a change to a peptide terminus are different specification fields. Ask both questions without merging them into the phrase KPV salt. Record any declared non-peptide constituents, and request the basis of the per-container mass. A nominal quantity label does not state the measured fraction attributable to the requested peptide. Do not apply a calculated correction from a generic purity claim or assume that three residues imply a fixed content basis.
Match documentation to the single compound
If KPV is ordered alone, request evidence naming that individual material. If it is a blend component, ask separately what documentation covers the input and what covers the finished mixture. Neither a KPV reference record nor a component report establishes the composition of a multi-component vial. Keep sample identity, lot mapping and method scope visible so the reviewer does not accidentally close a finished-material question using an unrelated component document.
Use a compact acceptance card
A useful KPV card has six lines: sequence, terminal state, supplied form, amount basis, container count and document scope. Mark each as requested, proposed or accepted. This is easier to audit than several messages saying the same peptide. When a line changes, update that field and obtain review rather than replacing the entire record silently. The result is a precise research-material request, not an effect claim or recommendation for personal use.
Before closing this review
- Residues remain in the intended order.
- A modified form is a separate proposal.
- Component and finished-blend evidence differ.
- Every accepted field has written confirmation.
Continue with review the relevant catalog record; prepare a precise material inquiry. Save the relevant product or guide link alongside the written response so another reviewer can reconstruct the decision.
Editorial scope: research-material procurement and document review. Not medical guidance, dosing instructions or a claim of suitability for human use. Requirements and availability must be confirmed for the quoted material.
